1 / 22

Overview

Overview. 2,6-naphthalene dicarboxylic acid (NDCA), ethylene diamine tetracetic acid (EDTA), and perfluoro-1,10-decane diol (PFDO) were used to charge invert CID product ions from several peptides from +1 to -1.

brygid
Download Presentation

Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Overview • 2,6-naphthalene dicarboxylic acid (NDCA), ethylene diamine tetracetic acid (EDTA), and perfluoro-1,10-decane diol (PFDO) were used to charge invert CID product ions from several peptides from +1 to -1. • Hypothetically, y-ions should charge invert from +1 to -1 more readily than b-ions, because y-ions have a carboxylate group on the C-terminus and b-ions do not. • Charge inversion likely occurs by the formation of a long-lived chemical complex2. • Selective charge inversion should depend on the differences in proton affinity of the b-ion and y-ion.

  2. Introduction • Using ion/ion reactions for charge inversion eliminates the need for high collision energies and gives product ions with little or no fragmentation1. • Differentiating y-ions from b-ions in CID spectra is useful for peptide and protein identification. • Identifying y-ions and b-ions in a CID spectrum without prior knowledge of the peptides’ sequence is tedious. • Charge inversion via ion/ion reactions is a desirable way todifferentiate between y-ions and b-ions because of the experimental control available. • Distinguishing y-ions from b-ions by charge inversion would facilitate sequencing and identification of unknown proteins.

  3. Approach • CID product ions of one of several peptides were charge inverted from +1 to -1 using three doubly charged negative reagent ions. • The relative proton affinities of y-ions and b-ions should play an important role in charge inversion. • The charge state dependent proton affinity of the reagent ion is an important factor in selective charge inversion of y-ions versus b-ions. • Selectively charge inverting y-ions from +1 to -1would make differentiating between y-ions and b-ions in CID spectra of unknown proteins a real possibility.

  4. Peptides PPGFSPFR RPPFSPFR RPPGFSPFR VDPVNFK ALILTLVS YGGFL Reagent Ions Experimental • Mass spectrometer: modified QTRAP 20003 • Ionization source: pulsed dual nano-ESI source EDTA NDCA PFDO

  5. CID ExperimentalSequence 2. Peptide CID 1. Isolate peptide +1/+2 +1 CID Product Ions 4. Charge Inverted CID 3. Isolate Reagent 4. Ion/Ion Charge Inversion Reaction -1 -2

  6. IQ2 IQ3 EX triggered -/+ HV Q1 Q2 Q3 Nano-ESI tip Nano-ESI tip triggered +/- HV ~ ~ ~ Modified QTRAP 2000 Q0 Pulsed Dual Nano-ESI Source

  7. Negative Reagent Ions PFDO EDTA NDCA

  8. B-ion/Y-ionCalculations • Density Functional Theory calculations [UB3LYP 6-31+G(d)] were performed on a model y1 ion and b2 ion4. • The proton affinities of the model y-ion and b-ion were calculated as shown below. PA = -ΔHrxn = -[ΔHf (Anion) + ΔHf (H+) – ΔHf (Neutral)]

  9. B-ion/Y-ion Structures B2 Anion Y1 Anion B2 Neutral Y1 Neutral

  10. Theoretical Predictions • When the reagent ion’s proton affinity is between the proton affinity of the y-ions and b-ions, y-ions were predicted to charge invert more efficiently: • Only y-ions have a C-terminal carboxylate group allowing y-ions to charge invert more easily from +1 to -1. • Calculations show the proton affinity of the b2 ion from diglycine is 6 kcal/mol greater than for the y1 ion of glycine. • Charge inversion selectivity is expected to be dependent on the acidity of the reagent ion.

  11. Experimental Results • All three positive to negative charge inversion reagents charge inverted CID product ions from all the peptides tested. • PFDO charge inverted CID product ions by complex formation only. • Both EDTA and NDCA charge inverted CID product ions by proton transfer only. • Both y-ions and b-ions were charge inverted by all three reagents, and none of the reagents selectively charge inverted y-ions versus b-ions.

  12. 1.3e7 6.5e6 700 800 900 1000 1100 1200 500 600 1.3e7 x2 6.5e6 1300 350 450 550 650 750 850 950 150 250 PPGFSPFR CID and charge inversion with PFDO M+2 y1 *= -NH3 or –H2O CID spectrum of Des R1 bradykinin PPGFSPFR y1* Positive Mode y3*, y3 b4 y4* y4 y6* y5 y6 y7 y1*+P Charge Inversion with PFDO by complex formation x2 P = PFDO - y1 + P - Negative Mode y3* + P y3 + P *= -NH3 or –H2O y4* + P y6* + P y4 + P y6 + P y7 + P y2 + P y2* + P y5 + P m/z

  13. 4e7 2e6 350 750 850 950 550 650 450 y6 M b8, M* 2e6 b7 b5, y4*, y4 y6* b7+H2O b8* M+Na y5 y3 y7 350 750 850 950 550 650 450 PPGFSPFR CID and charge inversion with NDCA y6 CID spectrum of Des R1 bradykinin PPGFSPFR *= -NH3 or –H2O Positive Mode b8, M* b7+H2O M b7 b5, y4*, y4 y6* b8* y5 y3 y7 M+Na 4e7 *= -NH3 or –H2O Charge inversion using 2,6-NDCA Negative Mode m/z

  14. 4e7 2e6 350 750 850 950 550 650 450 m/z PPGFSPFR CID and charge inversion with EDTA y6 CID spectrum of Des R1 bradykinin PPGFSPFR *= -NH3 or –H2O Positive Mode b8, M* b7+H2O M b7 b5, y4*, y4 y6* b8* y5 y3 y7 M+Na M Charge inversion using EDTA y6 *= -NH3 or –H2O x2 Negative Mode b7+H2O b8, M* b8* b7 y6* b5, y4*, y4 y5 y3 y7 M+Na

  15. Rel. Ab. Post Chg Inv. Charge Inversion Ratio = Rel. Ab. Pre Chg Inv. Charge Inversion of Des R1 (PPGFSPFR) with NDCA, EDTA, and PFDO Charge Inversion Ratio

  16. Rel. Ab. Post Chg Inv. Charge Inversion Ratio = Rel. Ab. Pre Chg Inv. Charge Inversion of VDPVNFK CID with NDCA, EDTA, and PFDO x2 Charge Inversion Ratio

  17. Rel. Ab. Post Chg Inv. Charge Inversion Ratio = Rel. Ab. Pre Chg Inv. Charge Inversion of ALILTLVS CID with NDCA, EDTA, and PFDO x10 x4 Charge Inversion Ratio

  18. Discussion • Overall y-ions were not charge inverted more selectively than b-ions using NDCA, EDTA, and PFDO. • NDCA has a higher overall charge inversion efficiency than EDTA or PFDO for all ions. • NDCA does not appear to preferentially charge invert any particular type of ion. • PFDO may have some preference for ions containing basic residues [Lys (K) and Arg (R)] and acidic residues [Glu (E) and Asp (D)]. • EDTA discriminates against the sodiated parent ion in the charge inversion process.

  19. Discussion • NDCA charge inverts b-ions and y-ions although NDCA’s calculated 2nd proton affinity was lower than the proton affinities of the model b-ion and y-ion (suggesting that NDCA would not charge invert b or y-ions). • The b-ions and y-ions studied experimentally likely had lower proton affinities of NDCA, EDTA, and PFDO because the experimentally studied b-ions and y-ions were composed of amino acids with polar groups that lowered the proton affinity of the b-ions and y-ions. • Functional groups and amino acid composition will affect the relative proton affinities of b-ions and y-ions.

  20. Conclusions • PFDO, NDCA, and EDTA are can be used as positive to negative charge inversion reagents by complex formation and by proton transfer. • Energy lowering interactions in the b-ions and y-ions studied experimentally probably prevented NDCA, EDTA, and PFDO from selectively charge inverting y-ions versus b-ions. • Factors such as the presence of acidic or basic residues also may play a role in charge inversion selectivity. • Selective charge inversion of y-ions rather than b-ions using these reagents is not possible, and other reagents or approaches are being investigated.

  21. Acknowledgments • Research sponsored by the Office of Basic Energy Sciences, Division of Chemical Sciences under Award No. DE-FG02-00ER15105. • Amy Facility at Purdue University.

  22. References • 1. M. He, J.F. Emory, S.A. McLuckey, Anal. Chem., 77 (2005) 3173-3182. • 2. J.M. Wells, P.A. Chrisman, S.A. McLuckey, J. Am. Chem. Soc., 125 (2003) 7238-7249. • 3. Y. Xia, X. Liang, S.A. McLuckey, J.Am. Soc. Mass Spectrom.,16 (2005) 1750-1756. • 4. B. Paizs, S. Suhai, Mass. Spectrom. Rev., 24 (2005) 508-548.

More Related